SCHEMBL9053833

SCHEMBL9053833

CCC(=O)c1cc2c(c(OS(=O)(=O)c3ccc(C)cc3)c1)OC(c1ccccc1)(c1ccccc1)O2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
GAA P10253 4/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
ALDH1A1 P00352 5/20 0.37
LMNA P02545 2/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 3/20 0.36
RECQL P46063 1/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ENPP2 Q13822 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9063668 0.87 KMT2A (0.40) SMN1; SMN2NPC1RAB9AGAAKMT2A
SCHEMBL9052756 0.86 GAA (0.38) SMN1; SMN2NPC1RAB9AGAAKMT2A
SCHEMBL9057604 0.83 KMT2A (0.40) GAAKMT2AMEN1ESR1ESR2
SCHEMBL9062465 0.78 ALDH1A1 (0.50) SMN1; SMN2GAAKMT2AMEN1ALDH1A1
SCHEMBL9058390 0.77 TAS2R14 (0.39) SMN1; SMN2NPC1RAB9A
SCHEMBL9063431 0.77 MEN1 (0.40) GAAKMT2AMEN1ALDH1A1LMNA
SCHEMBL9058113 0.77 ENPP3 (0.39) ENPP2
SCHEMBL9053411 0.76 GAA (0.43) GAAKMT2AMEN1ESR1ESR2
SCHEMBL9057622 0.76 CYP1A2 (0.42) SMN1; SMN2NPC1RAB9AGAAKMT2A
SCHEMBL9056672 0.74 TSHR (0.33) SMN1; SMN2NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996008483-A1 GALLIC ACID DERIVATIVES, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS ROUSSEL UCLAF (FR) 1996-03-21 WO disclosed